Literature DB >> 18394775

Tightly regulated gene expression in human hematopoietic stem cells after transduction with helper-dependent Ad5/35 vectors.

Hongje Wang1, Hua Cao, Martin Wohlfahrt, Hans-Peter Kiem, André Lieber.   

Abstract

OBJECTIVE: Inducible and transient expression of transcription factors, growth factors, or mitogenic factors can be used to influence proliferation or differentiation of hematopoietic progenitor/stem cells (HSC). Furthermore, transient expression of proteins with site-specific endonuclease activity, potentially, can support targeted integration of exogenous transgenes into specific sites in the genome, a task that is currently a focus in development of gene therapy vectors.
MATERIALS AND METHODS: We constructed a set of helper-dependent adenovirus (Ad) vectors with serotype 35 fiber knob domains (HD-Ad5/35), which can efficiently transduce human CD34(+) cells, particularly subsets with potential stem cell capacity. These vectors contain Tet-inducible expression systems that were shielded by insulators and transcription stop signals to minimize unspecific interference by transcriptional elements present in viral and stuffer DNA. We compared two vectors, containing a fusion between the Krüppel-associated box (KRAB) domain and the tetracycline repressor (HD-Ad5/35.Tet-1) or an autoregulated rtTA (HD-Ad5/35.Tet-2) for regulated transgene expression in Mo7e cells, a model for HSC, and primary human CD34(+) cells.
RESULTS: HD-Ad5/35.Tet-1 conferred lower background expression than HD-Ad5/35.Tet-2, although levels of induced gene expression were higher for HD-Ad5/35.Tet-2. In CD34(+) cells, while HD-Ad5/35.Tet-1 allowed for activated gene expression in all transduced cells, induced gene expression from HD-Ad5/35.Tet-2 was restricted to a small subset of CD34(+) cells. Importantly, clonogeneic assays and repopulation studies in nonobese diabetic/severe combined immunodeficient mice showed that both HD-Ad5/35.Tet-1 and -2 vectors mediated induced gene expression in primitive hematopoietic cells. These studies also confirmed that transduction of CD34(+) cells with HD-Ad5/35 vectors is not associated with cytotoxicity, a problem observed with first-generation Ad5/35 vectors.
CONCLUSIONS: Both HD-Ad5/35 vector expression systems confer tightly regulated, transient transgene expression in human HSC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394775      PMCID: PMC2517261          DOI: 10.1016/j.exphem.2008.01.014

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  31 in total

1.  Optimization of the helper-dependent adenovirus system for production and potency in vivo.

Authors:  V Sandig; R Youil; A J Bett; L L Franlin; M Oshima; D Maione; F Wang; M L Metzker; R Savino; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo.

Authors:  D S Steinwaerder; A Lieber
Journal:  Gene Ther       Date:  2000-04       Impact factor: 5.250

3.  Silencing of RNA polymerases II and III-dependent transcription by the KRAB protein domain of KOX1, a Krüppel-type zinc finger factor.

Authors:  P Moosmann; O Georgiev; H J Thiesen; M Hagmann; W Schaffner
Journal:  Biol Chem       Date:  1997-07       Impact factor: 3.915

4.  A versatile tool for conditional gene expression and knockdown.

Authors:  Jolanta Szulc; Maciej Wiznerowicz; Marc-Olivier Sauvain; Didier Trono; Patrick Aebischer
Journal:  Nat Methods       Date:  2006-02       Impact factor: 28.547

5.  Modulation of the specificity and activity of a cellular promoter in an adenoviral vector.

Authors:  Q Shi; Y Wang; R Worton
Journal:  Hum Gene Ther       Date:  1997-03-01       Impact factor: 5.695

6.  A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma.

Authors:  P L Hallenbeck; Y N Chang; C Hay; D Golightly; D Stewart; J Lin; S Phipps; Y L Chiang
Journal:  Hum Gene Ther       Date:  1999-07-01       Impact factor: 5.695

7.  Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.

Authors:  A Lieber; C Y He; I Kirillova; M A Kay
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression.

Authors:  Hongjie Wang; Dmitry M Shayakhmetov; Tobias Leege; Michael Harkey; Qiliang Li; Thalia Papayannopoulou; George Stamatoyannopolous; André Lieber
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  cis and trans requirements for the selective packaging of adenovirus type 5 DNA.

Authors:  M Gräble; P Hearing
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

View more
  12 in total

1.  A rapid protocol for construction and production of high-capacity adenoviral vectors.

Authors:  Lorenz Jager; Martin A Hausl; Christina Rauschhuber; Nicola M Wolf; Mark A Kay; Anja Ehrhardt
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 2.  In Vivo Hematopoietic Stem Cell Transduction.

Authors:  Maximilian Richter; Daniel Stone; Carol Miao; Olivier Humbert; Hans-Peter Kiem; Thalia Papayannopoulou; André Lieber
Journal:  Hematol Oncol Clin North Am       Date:  2017-10       Impact factor: 3.722

3.  Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.

Authors:  Chang Li; Nikoletta Psatha; Pavel Sova; Sucheol Gil; Hongjie Wang; Jiho Kim; Chandana Kulkarni; Cristina Valensisi; R David Hawkins; George Stamatoyannopoulos; André Lieber
Journal:  Blood       Date:  2018-05-22       Impact factor: 22.113

4.  In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors.

Authors:  Maximilian Richter; Kamola Saydaminova; Roma Yumul; Rohini Krishnan; Jing Liu; Eniko-Eva Nagy; Manvendra Singh; Zsuzsanna Izsvák; Roberto Cattaneo; Wolfgang Uckert; Donna Palmer; Philip Ng; Kevin G Haworth; Hans-Peter Kiem; Anja Ehrhardt; Thalia Papayannopoulou; André Lieber
Journal:  Blood       Date:  2016-08-23       Impact factor: 22.113

5.  Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation.

Authors:  Kamola Saydaminova; Xun Ye; Hongjie Wang; Maximilian Richter; Martin Ho; HongZhuan Chen; Ning Xu; Jin-Soo Kim; Eirini Papapetrou; Michael C Holmes; Philip D Gregory; Donna Palmer; Philip Ng; Anja Ehrhardt; André Lieber
Journal:  Mol Ther Methods Clin Dev       Date:  2015-01-14       Impact factor: 6.698

Review 6.  The therapeutic landscape of HIV-1 via genome editing.

Authors:  Alexander Kwarteng; Samuel Terkper Ahuno; Godwin Kwakye-Nuako
Journal:  AIDS Res Ther       Date:  2017-07-14       Impact factor: 2.250

7.  Transcriptional control of Flt3 ligand targeted by fluorouracil-induced Egr-1 promoter in hematopoietic damage.

Authors:  Nan Du; Xuetao Pei; Jinming Zhou; Hui Zhao; Xiaosong Li; Yan Fu; Yixin Hao
Journal:  J Biomed Sci       Date:  2009-09-21       Impact factor: 8.410

Review 8.  Cellular reprogramming of human peripheral blood cells.

Authors:  Xiao-Bing Zhang
Journal:  Genomics Proteomics Bioinformatics       Date:  2013-09-21       Impact factor: 7.691

9.  A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced Integration.

Authors:  Philip Boehme; Wenli Zhang; Manish Solanki; Eric Ehrke-Schulz; Anja Ehrhardt
Journal:  Mol Ther Nucleic Acids       Date:  2016-07-19       Impact factor: 10.183

10.  Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies.

Authors:  Chang Li; Nikoletta Psatha; Hongjie Wang; Manvendra Singh; Himanshu Bhusan Samal; Wenli Zhang; Anja Ehrhardt; Zsuzsanna Izsvák; Thalia Papayannopoulou; André Lieber
Journal:  Mol Ther Methods Clin Dev       Date:  2018-02-15       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.